AI use case

AI-Designed Molecules Entering Clinical Trials

Exscientia Outlines Robot and AI Use in New Drug Discovery Approach Exscientia, a pharmaceutical AI company, has outlined its approach to integrating robotics and AI in drug dis…

Browse catalog

At a glance

Core facts from this catalog record. Primary narrative lives in the hero above; full raw fields follow in the next section.

Company/Organization: Exscientia
Industry: Biotechnology
Location: Oxford

Record fields

Every column from the source row, in stable order. URLs open in a new tab.

Title

AI-Designed Molecules Entering Clinical Trials

Content

Exscientia Outlines Robot and AI Use in New Drug Discovery Approach Exscientia, a pharmaceutical AI company, has outlined its approach to integrating robotics and AI in drug discovery, creating an automated platform for rapid identification and optimization of drug candidates. Integrated Approach: 1. Automated compound synthesis and testing throughput has been dramatically increased through robotic systems. 2. Generative AI designs novel molecules with target properties. 3. Bayesian optimization algorithms prioritize experiments to find optimal compounds efficiently. 4. ML models predict which experiments are most likely to yield useful data. AI Platform Capabilities: Exscientia's AI-driven approach reduces the time required to identify promising drug candidates from years to months, potentially transforming the economics of drug development.

URL

https://www.clinicaltrialsarena.com/news/exscientia-outline-robot-and-ai-use-in-drug-discovery-workflow/

Continue exploring AI deployments in the catalog.

Back to use cases